Immunology

  1. Human KIR + CD8 + T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19

    1. Jing Li
    2. Maxim Zaslavsky
    3. Yapeng Su
    4. Michael J. Sikora
    5. Vincent van Unen
    6. Asbjørn Christophersen
    7. Shin-Heng Chiou
    8. Liang Chen
    9. Jiefu Li
    10. Xuhuai Ji
    11. Julie Wilhelmy
    12. Alana M. McSween
    13. Brad A. Palanski
    14. Venkata Vamsee Aditya Mallajosyula
    15. Gopal Krishna R. Dhondalay
    16. Kartik Bhamidipati
    17. Joy Pai
    18. Lucas B. Kipp
    19. Jeffrey E. Dunn
    20. Stephen L. Hauser
    21. Jorge R. Oksenberg
    22. Ansuman T. Satpathy
    23. William H. Robinson
    24. Lars M. Steinmetz
    25. Chaitan Khosla
    26. Paul J. Utz
    27. Ludvig M. Sollid
    28. James R. Heath
    29. Nielsen Q. Fernandez-Becker
    30. Kari C. Nadeau
    31. Naresha Saligrama
    32. Mark M. Davis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617

    1. Lei Peng
    2. Yingxia Hu
    3. Madeleine C. Mankowski
    4. Ping Ren
    5. Rita E. Chen
    6. Jin Wei
    7. Min Zhao
    8. Tongqing Li
    9. Therese Tripler
    10. Lupeng Ye
    11. Ryan D. Chow
    12. Zhenhao Fang
    13. Chunxiang Wu
    14. Matthew B. Dong
    15. Matthew Cook
    16. Guilin Wang
    17. Paul Clark
    18. Bryce Nelson
    19. Daryl Klein
    20. Richard Sutton
    21. Michael S. Diamond
    22. Craig B. Wilen
    23. Yong Xiong
    24. Sidi Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. IL4I1 binds to TMPRSS13 and competes with SARS-Cov2 Spike

    1. Jérôme Gatineau
    2. Charlotte Nidercorne
    3. Aurélie Dupont
    4. Marie-Line Puiffe
    5. José L Cohen
    6. Valérie Molinier-Frenkel
    7. Florence Niedergang
    8. Flavia Castellano

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Broad and Long-lasting Immune Response against SARS-CoV-2 Omicron and Other Variants by PIKA-Adjuvanted Recombinant SARS-CoV-2 Spike (S) Protein Subunit Vaccine (YS-SC2-010)

    1. Yuan Liu
    2. Nan Zhang
    3. Bin Wang
    4. Yi Zhang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Two doses of mRNA vaccine elicit cross-neutralizing memory B-cells against SARS-CoV-2 Omicron variant

    1. Ryutaro Kotaki
    2. Yu Adachi
    3. Saya Moriyama
    4. Taishi Onodera
    5. Shuetsu Fukushi
    6. Takaki Nagakura
    7. Keisuke Tonouchi
    8. Kazutaka Terahara
    9. Lin Sun
    10. Tomohiro Takano
    11. Ayae Nishiyama
    12. Masaharu Shinkai
    13. Kunihiro Oba
    14. Fukumi Nakamura-Uchiyama
    15. Hidefumi Shimizu
    16. Tadaki Suzuki
    17. Takayuki Matsumura
    18. Masanori Isogawa
    19. Yoshimasa Takahashi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Waning immune responses against SARS-CoV-2 among vaccinees in Hong Kong

    1. Qiaoli Peng
    2. Runhong Zhou
    3. Yuewen Wang
    4. Meiqing Zhao
    5. Na Liu
    6. Shuang Li
    7. Haode Huang
    8. Dawei Yang
    9. Ka-Kit Au
    10. Hui Wang
    11. Kwan Man
    12. Kwok-Yung Yuen
    13. Zhiwei Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice

    1. Ashley Zani
    2. Adam D. Kenney
    3. Jeffrey Kawahara
    4. Adrian C. Eddy
    5. Xiao-Liang Wang
    6. Mahesh KC
    7. Mijia Lu
    8. Emily A. Hemann
    9. Jianrong Li
    10. Mark E. Peeples
    11. Luanne Hall-Stoodley
    12. Adriana Forero
    13. Chuanxi Cai
    14. Jianjie Ma
    15. Jacob S. Yount

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Structural basis for antibody resistance to SARS-CoV-2 omicron variant

    1. Gabriele Cerutti
    2. Yicheng Guo
    3. Lihong Liu
    4. Zhening Zhang
    5. Liyuan Liu
    6. Yang Luo
    7. Yiming Huang
    8. Harris H. Wang
    9. David D. Ho
    10. Zizhang Sheng
    11. Lawrence Shapiro

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Anti-SARS-CoV-2 human antibodies retaining neutralizing activity against SARS-CoV-2 B.1.1.529 (omicron)

    1. Maya Imbrechts
    2. Winnie Kerstens
    3. Madina Rasulova
    4. Thomas Vercruysse
    5. Wim Maes
    6. Louanne Ampofo
    7. Karen Ven
    8. Jeroen Lammertyn
    9. Karen Vanhoorelbeke
    10. Nico Callewaert
    11. Johan Neyts
    12. Kai Dallmeier
    13. Paul Declerck
    14. Hendrik Jan Thibaut
    15. Nick Geukens

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies

    1. Anne-Cathrine S. Vogt
    2. Lukas Jörg
    3. Byron Martina
    4. Pascal S. Krenger
    5. Xinyue Chang
    6. Andris Zeltins
    7. Monique Vogel
    8. Mona O. Mohsen
    9. Martin F. Bachmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 81 of 174 Next